Changes to a key protein amplified its natural ability to counter kidney disease, according to UAB research. The team now will work to confirm those results and conduct toxicity and dosing studies that would need before they could conduct human clinical trials. The study was published in the journal Nature Medicine.
First mechanism-based drug design underway for kidney disease
Published in Research & Scholarship